US Stocks
/
Corvus Pharmaceuticals, Inc. Share Price
Corvus Pharmaceuticals, Inc. Share Price

Corvus Pharmaceuticals, Inc. Share Price

NASDAQ: CRVS | Small Cap
$10.52
+$0.29 (2.83%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Corvus Pharmaceuticals, Inc. Stock Performance

Open
$10.17
Prev. Close
$10.23
Circuit Range
N/A
Day Range
$10.08 - $10.70
Year Range
$6.42 - $26.87
Volume
75,581
Average Traded
$10.40

Corvus Pharmaceuticals, Inc. Share Price Today

As of 10 October 2026, Corvus Pharmaceuticals, Inc.'s share price is $10.52. The stock opened at $10.17, compared to its previous close of $10.23. During today's trading session, Corvus Pharmaceuticals, Inc.'s share price traded between $10.08 and $10.70, with an average price of $10.39. Over the past 52 weeks, the stock has recorded a high of $26.87 and a low of $6.42. In terms of performance, Corvus Pharmaceuticals, Inc.'s share price has declined by 30.70% over the last six months and is up 30.86% on a year-on-year basis.

Corvus Pharmaceuticals, Inc. Share Price Chart

$10.08$10.70
L
Show Current Price
H

Corvus Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$830.71M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.64
Revenue (TTM)
$0.00
Return On Equity (TTM)
-24.02%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-76.77%

Corvus Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$10.16-$12.32-$13.69-$17.96
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-21.26%-11.12%-31.19%

Corvus Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$41.31-$27.03-$62.29-$15.28
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A34.57%-130.45%75.47%

About Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Corvus Pharmaceuticals, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$11.47
$10.51
-8.93%
Sep 2026
$14.05
$11.54
-21.66%
Aug 2026
$13.19
$14.72
+11.13%
Jul 2026
$14.90
$13.25
-11.49%
Jun 2026
$12.28
$14.97
+20.43%
May 2026
$15.18
$12.43
-18.12%
Apr 2026
$15.21
$15.18
+3.62%
Mar 2026
$17.78
$14.65
-19.86%
Feb 2026
$20.84
$18.28
-11.61%
Jan 2026
$7.66
$20.68
+169.10%
Dec 2025
$9.00
$7.68
-16.06%
Nov 2025
$7.82
$9.15
+13.88%

CRVS Share Price FAQs

What is Corvus Pharmaceuticals, Inc. share price today?

chevron-up
Corvus Pharmaceuticals, Inc. share price today is $10.52 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Corvus Pharmaceuticals, Inc. stock?

chevron-up
The 52 week high of Corvus Pharmaceuticals, Inc. stock is $26.87, while the 52 week low is $6.42 as of 10 Oct '26.

What is CRVS's market capitalisation today?

chevron-up
CRVS market capitalisation is $830.71M as of October 10, 2026, at 9:10 am IST.

What is CRVS's net income for the last quarter?

chevron-up
CRVS's net income for the last quarter is -17.96B USD.

What is the 5 year returns of CRVS?

chevron-up
The 5 year returns of CRVS is 132.23% as on 10 Oct '26.

What is the high & low stock price of CRVS today?

chevron-up
CRVS stock price hit a high of $10.70 and low of $10.08 as of 10 Oct '26.

Can I buy CRVS shares in India?

chevron-up
Yes. You can buy CRVS in India by opening an international trading account.